BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Dr. Kelly and her colleagues synthesized a panel of PDCs aimin
 g at the precise treatment of pulmonary fibrosis\, where nintedanib - a p
 otent kinase inhibitor approved for the treatment of idiopathic pulmonary
  fibrosis - and a peptidomimetic targeting αVβ6 integrin - which is a rec
 eptor overexpressed in fibrotic tissues - are connected by different link
 ers. Given the promising&nbsp\;in vitro&nbsp\;results of one synthesized 
 PDC\, the&nbsp\;in vivo&nbsp\;antifibrotic activity is currently under ev
 aluation in mice models of pulmonary fibrosis.\n
DTEND:20241127T111500
DTSTAMP:20260512T220828Z
DTSTART:20241127T100000
LOCATION:Ramsey Road\, Shirley\, New York\, 11967\,
SEQUENCE:0
SUMMARY:Dr. Kelly and her colleagues synthesized a panel of PDCs aiming at
  the precise treatment of pulmonary fibrosis\, where nintedanib - a poten
 t kinase...
UID:ed846a34-a0a5-4826-80e7-7cc7d8fb1fec
END:VEVENT
END:VCALENDAR